1-20 of 24
Plasma Cell Disorders
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Retreatment of multiple myeloma with previously refractory drugs

Utkarsh Goel, Charalampos Charalampous, Prashant Kapoor, Moritz Binder, Francis K. Buadi, David Dingli, Angela Dispenzieri, Amie Fonder, Morie A. Gertz, Wilson I. Gonsalves, Suzanne R. Hayman, Miriam A. Hobbs, Yi L. Hwa, Taxiarchis Kourelis, Martha Q. Lacy, Nelson Leung, Yi Lin, Rahma M. Warsame, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar
Journal: Blood Advances
Blood Adv (2024) 8 (24): 6321–6328.
https://doi.org/10.1182/bloodadvances.2024014723
Published: 2024
Includes: Supplemental data
Journal Articles

Cumulative Deficits Frailty Index and Relationship Status Predict Survival in Multiple Myeloma

Nadine Abdallah, Paul Dizona, Amanika Kumar, Betsy LaPlant, Terri Menser, Gavin Schaeferle, Sarah Aug, Megan Weivoda, Angela Dispenzieri, Francis K Buadi, Rahma Warsame, Joselle Cook, Martha Q Lacy, Suzanne R Hayman, Morie A Gertz, S. Vincent Rajkumar, Shaji K Kumar
Journal: Blood Advances
Blood Adv bloodadvances.2024014624.
https://doi.org/10.1182/bloodadvances.2024014624
Published: 2024
Includes: Supplemental data
Journal Articles

NAD+ METABOLISM RESTRICTION BOOSTS HIGH-DOSE MELPHALAN EFFICACY IN PATIENTS WITH MULTIPLE MYELOMA

Debora Soncini, Pamela Becherini, Francesco Ladisa, Silvia Ravera, Adithya Chedere, Elisa Gelli, Giulia Giorgetti, Claudia Martinuzzi, Francesco Piacente, Dr, Luca Mastracci, Claudia Veneziano, Dr, Gianluca Santamaria, Dr, Fiammetta Monacelli, Moustafa S Ghanem, Antonia Cagnetta, Fabio Guolo, Dr, Matteo Garibotto, Sara Aquino, Mario Passalacqua, Santina Bruzzone, Axel Bellotti, Michel A. Duchosal, Aimable A Nahimana, Emanuele Angelucci, Chandra Nagasuma, Prof, Alessio Nencioni, Roberto Massimo Lemoli, Michele Cea, Prof
Journal: Blood Advances
Blood Adv bloodadvances.2024013425.
https://doi.org/10.1182/bloodadvances.2024013425
Published: 2024
Includes: Supplemental data
Journal Articles

Health care Systems as Determinants of Outcomes in Multiple Myeloma: Final Results from the Latin American MYLACRE Study

Vania Tietsche de Moraes Hungria, Rafael D Gaiolla, Kenny Galvez, Guillermina Remaggi, Natalia Schutz, Rosane Isabel Bittencourt, Angelo Maiolino, Guillermo Enrique Quintero-Vega, Maria Silvana Cugliari, Walter Moises Tobias Braga, Carolina Colaco Villarim, Edvan de Queiroz Crusoé, Alicia Ines Ines Enrico, MD, Gaston Caeiro, Jandey Gloria Bigonha, Fernanda Lemos Moura, Jair Figueroa Emiliani, Dr., Claudia Sossa-Melo, Milton Lombana, Huiling Pei, Mariana Fernandez, Jaqueline Saes, Damila Cristina Trufelli
Journal: Blood Advances
Blood Adv bloodadvances.2024013838.
https://doi.org/10.1182/bloodadvances.2024013838
Published: 2024
Journal Articles

Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma

Inés Zugasti, Marta Tormo-Ratera, Aina Oliver-Caldes, Juan Carlos Soler-Perromat, Veronica Gonzalez-Calle, David F Moreno, Valentín Cabañas, Nieves Lopez-Muñoz, Alvaro Bartolome-Solanas, Marta Español-Rego, Juan Luis Reguera-Ortega, Laura Rosiñol, Lucia Lopez-Corral, Natalia Tovar, Luis Gerardo Rodríguez-Lobato, Rosa Maria Alvarez Perez, Sara Varea, Eulàlia Olesti, Adolfo Gomez Grande, Laura Frutos, Pilar Tamayo, Manel Juan, José M Moraleda, Álvaro Urbano-Ispizua, Europa Azucena Azucena González-Navarro, Joaquín Martínez-López, Maria-Victoria Mateos, Xavier Tomas, Xavier Setoain, Carlos Fernández de Larrea
Journal: Blood Advances
Blood Adv bloodadvances.2024014360.
https://doi.org/10.1182/bloodadvances.2024014360
Published: 2024
Includes: Supplemental data
Journal Articles

Quadruplet regimens for patients with newly diagnosed multiple myeloma: a systematic review and meta-analysis

Mohammad S. Ebraheem, Rajshekhar Chakraborty, Bram Rochwerg, Alissa Visram, Ghulam Rehman Mohyuddin, Christopher P. Venner, Irwindeep Sandhu, Arleigh McCurdy, Thierry Facon, Maria-Victoria Mateos, Hira Mian
Journal: Blood Advances
Blood Adv (2024) 8 (23): 5993–6002.
https://doi.org/10.1182/bloodadvances.2024014139
Published: 2024
Includes: Supplemental data
Journal Articles

Febrile neutropenia in patients with Duffy-null–associated neutrophil counts and multiple myeloma or AL amyloidosis

Maya Abdallah, Frances Arters, Jasmine Patel, Camille Edwards, Adam Lerner, Fabio Petrocca, Margaux Dockerty, Brittany Fuller, Alicia Godfrey, Andrew Staron, Vaishali Sanchorawala, J. Mark Sloan, Kimberly Bertrand, Raphael Szalat
Journal: Blood Advances
Blood Adv (2024) 8 (23): 5935–5938.
https://doi.org/10.1182/bloodadvances.2024013453
Published: 2024
Includes: Supplemental data
Journal Articles

Improving reporting of infection events in clinical trials

Clinical Trials & Observations
Heinz Ludwig, Nikhil C. Munshi, Evangelos Terpos, Noopur Raje, Philippe Moreau, Ajay Nooka
Journal: Blood Advances
Blood Adv (2024) 8 (22): 5927–5928.
https://doi.org/10.1182/bloodadvances.2024014102
Published: 2024
Journal Articles

MRD-negative duration following latest line of therapy predicts long-term PFS in real-world multiple myeloma patients

Lucia Y Chen, Santiago Thibaud, Saoirse Bodnar, Ajai Chari, Joshua Richter, Hearn Jay Cho, Larysa J Sanchez, Cesar Rodriguez, Adriana C Rossi, Shambavi Richard, Samir Parekh, Sundar Jagannath
Journal: Blood Advances
Blood Adv bloodadvances.2024014097.
https://doi.org/10.1182/bloodadvances.2024014097
Published: 2024
Journal Articles

Defying the odds: 30 years in AL amyloidosis research—recent barriers to clinical trial enrollment

Clinical Trials & Observations
Vaishali Sanchorawala, Bruna Barroso, Anthony Shelton, Elise Goetz, Lisa Mendelson, Tracy Joshi, Natasha Burke, J. Mark Sloan, Andrew Staron
Journal: Blood Advances
Blood Adv (2024) 8 (22): 5826–5828.
https://doi.org/10.1182/bloodadvances.2024014262
Published: 2024
Journal Articles

Lymphopenia Predicts Poor Outcomes in Newly Diagnosed Multiple Myeloma

Grace Marie Ferri, Cenk Yildirim, Nhan V. Do, Mary T. Brophy, Joseph Park, Nikhil C. Munshi, Nathanael R Fillmore, Camille V. Edwards
Journal: Blood Advances
Blood Adv bloodadvances.2024014125.
https://doi.org/10.1182/bloodadvances.2024014125
Published: 2024
Includes: Supplemental data
Journal Articles

Comparison of patients with myeloma receiving zoledronic acid vs denosumab: a nationwide retrospective cohort study

Ghulam Rehman Mohyuddin, Jenny S. Guadamuz, Mustafa S. Ascha, Brian C.-H. Chiu, Pritesh R. Patel, Karen Sweiss, Rebecca Rohrer, Douglas Sborov, Gregory S. Calip
Journal: Blood Advances
Blood Adv (2024) 8 (21): 5539–5541.
https://doi.org/10.1182/bloodadvances.2024013600
Published: 2024
Includes: Supplemental data
Journal Articles

Cytopenias in BCMA CAR T: unraveling inflammatory mechanisms

Adam S. Sperling
Journal: Blood Advances
Blood Adv (2024) 8 (21): 5527–5528.
https://doi.org/10.1182/bloodadvances.2024014308
Published: 2024
Journal Articles

Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in multiple myeloma

Maria Luisa Palacios-Berraquero, Paula Rodriguez-Marquez, Maria Erendira Calleja-Cervantes, Nerea Berastegui, Aintzane Zabaleta, Leire Burgos, Diego Alignani, Patxi San Martin-Uriz, Amaia Vilas-Zornoza, Saray Rodriguez-Diaz, Susana Inoges, Ascensión Lopez-Diaz de Cerio, Sofia Huerga, Esteban Tamariz, Jose Rifon, Ana Alfonso-Pierola, Juan Jose Lasarte, Bruno Paiva, Mikel Hernaez, Paula Rodriguez-Otero, Jesus San-Miguel, Teresa Ezponda, Juan Roberto Rodriguez-Madoz, Felipe Prosper
Journal: Blood Advances
Blood Adv (2024) 8 (21): 5479–5492.
https://doi.org/10.1182/bloodadvances.2023012522
Published: 2024
Includes: Supplemental data
Journal Articles

Delayed neutrophil recovery following BCMA CAR-T therapy in Duffy-null myeloma does not impact severe infections or survival

Zachary M Avigan, Saoirse Bodnar, Darren Pan, Jerrel Lewis Catlett, II, Joshua Richter, Larysa J Sanchez, Cesar Rodriguez, Adriana C Rossi, Shambavi Richard, Sundar Jagannath, Hearn Jay Cho, Samir Parekh, Santiago Thibaud
Journal: Blood Advances
Blood Adv bloodadvances.2024014255.
https://doi.org/10.1182/bloodadvances.2024014255
Published: 2024
Includes: Supplemental data
Journal Articles

Class II ferroptosis inducers are a novel therapeutic approach for t(4;14)-positive multiple myeloma

Jiasi Zhang, Yuxi Liu, Liping Zuo, Fengjuan Fan, Han Yan, Fei Zhao, Junying Li, Chi Ma, Qun Li, Aoshuang Xu, Jian Xu, Bo Zhang, Yu Hu, Chunyan Sun
Journal: Blood Advances
Blood Adv (2024) 8 (19): 5022–5038.
https://doi.org/10.1182/bloodadvances.2023010335
Published: 2024
Includes: Supplemental data
Journal Articles

Alliance A061202: ixazomib, pomalidomide, and dexamethasone for patients with lenalidomide-refractory MM in first relapse

Clinical Trials & Observations
Peter Voorhees, Vera Suman, Yvonne Efebera, Noopur Raje, Sascha Tuchman, Cesar Rodriguez, Jacob Laubach, Misty Bova-Solem, Destin Carlisle, Saad Usmani, Philip McCarthy, Paul G. Richardson
Journal: Blood Advances
Blood Adv (2024) 8 (19): 5039–5050.
https://doi.org/10.1182/bloodadvances.2024013623
Published: 2024
Includes: Supplemental data
Journal Articles

Proposal for harmonizing the reporting of infections during treatment with bispecific antibodies in multiple myeloma

Clinical Trials & Observations
Heinz Ludwig, Nikhil C. Munshi, Evangelos Terpos, Ilvy Schweitzer, Noopur Raje, Philippe Moreau, Ajay Nooka
Journal: Blood Advances
Blood Adv (2024) 8 (18): 4979–4982.
https://doi.org/10.1182/bloodadvances.2024013461
Published: 2024
Includes: Supplemental data
Journal Articles

Anti-BCMA–engineered exosomes for bortezomib-targeted delivery in multiple myeloma

Shushu Yuan, Qi Li, Chuan He, Mengli Bing, Xinyun Zhang, Hao Xu, Zhiming Wang, Meifang Zhao, Yucheng Zhang, Yali Chai, Bingzong Li, Wenzhuo Zhuang
Journal: Blood Advances
Blood Adv (2024) 8 (18): 4886–4899.
https://doi.org/10.1182/bloodadvances.2023012464
Published: 2024
Includes: Supplemental data
Journal Articles

Halting multiple myeloma with MALT1 inhibition: suppressing BCMA-induced NF-κB and inducing immunogenic cell death

Yao Yao, Mei Yuan, Min Shi, Wenyu Li, Yuqian Sha, Yan Zhang, Canli Yuan, Jianping Luo, Zhenyu Li, Chengcheng Liao, Kailin Xu, Mingshan Niu
Journal: Blood Advances
Blood Adv (2024) 8 (15): 4003–4016.
https://doi.org/10.1182/bloodadvances.2023012394
Published: 2024
Includes: Supplemental data